| Followers | 200 |
| Posts | 25597 |
| Boards Moderated | 0 |
| Alias Born | 04/03/2010 |
Thursday, August 04, 2022 9:00:05 AM
Not really the right measure. Data is not out and bios tend to issue lots of shares to pay bills as they head to a trials conclusion and go for licensing. This was an exceptionally long trial, and it turns out that was for good reason. She could have ended it 5 years ago and just said, “You know, I was told to hold out for 5 more years, but I’ve got better things to do. See ya!”
400+ failures of very promising companies and some of the were championed by such leading lights as AF, failed completely, for GBM alone.
Looks like she and is investors have a winner in DCVax-L.
Additionally, over 5 years up something like 195%, and over 2 years 100%, and YTD basically flat, I think a lot of investors right now, given the macroeconomic situation, would call that pretty fabulous.
So yeah, there are those who blow smoke, but not really the full truth or even the partial truth in most instances. And yes, the shorting of the stock did do a lot of damage at one point, but that is not her fault. There are bad players in the markets and they love to target small bios like this one because it is easy money. Retail is easily deceived, and shorting makes a lot of money fast and easily. It’s a big transfer from the many small pockets of retail right into the treasury of robber baron hedge fund managers, who then pay that out to their investors who don’t care what evils were perpetrated in their names, just that it made them rich. It’s a fine tradition that goes back to piracy on the high seas.
400+ failures of very promising companies and some of the were championed by such leading lights as AF, failed completely, for GBM alone.
Looks like she and is investors have a winner in DCVax-L.
Additionally, over 5 years up something like 195%, and over 2 years 100%, and YTD basically flat, I think a lot of investors right now, given the macroeconomic situation, would call that pretty fabulous.
So yeah, there are those who blow smoke, but not really the full truth or even the partial truth in most instances. And yes, the shorting of the stock did do a lot of damage at one point, but that is not her fault. There are bad players in the markets and they love to target small bios like this one because it is easy money. Retail is easily deceived, and shorting makes a lot of money fast and easily. It’s a big transfer from the many small pockets of retail right into the treasury of robber baron hedge fund managers, who then pay that out to their investors who don’t care what evils were perpetrated in their names, just that it made them rich. It’s a fine tradition that goes back to piracy on the high seas.
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
